Skip to main content

Table 3 Pyridoxine effect on the lipid composition (mol %) and fluorescence anisotropy (rs) of DPH in erythrocyte membranes

From: Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine

  

Days of treatment

 
 

Basal 1

30

60

Basal 2

Phospholipids

65.8 ± 0.9a

57.3 ± 0.5b

57.8 ± 0.8b

58.0 ± 1.3b

Cholesterol

33.2 ± 0.9a

38.2 ± 0.6b

37.5 ± 0.8b

39.1 ± 1.3b

Triglyceride

0.4 ± 0.03a

2.0 ± 0.1b

2.1 ± 0.1b

1.0 ± 0.2c

Free fatty acids

0.6 ± 0.01a

2.5 ± 0.1b

2.6 ± 0.1b

1.9 ± 0.2c

Cholesterol/phospholipids

0.50

0.67

0.65

0.67

rs

0.235 ± 0.001a

0.249 ± 0.002b

0.249 ± 0.002b

0.253 ± 0.002a

  1. Data are the mean ± SEM. Values not bearing the same superscript letter are significantly different at P < 0.05.